October 23, 2022 — A new randomized study confirms that men with high-risk prostate cancer can be treated with five versus eight weeks of radiation therapy. The phase III clinical trial is the first to confirm the safety and efficacy of a moderately shortened course of radiation exclusively for patients with high-risk disease.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now